Company intelligence / Profile preview

Zero Pharm

Anyang-si, Gyeonggi-do, South Korea

Ownership: Private
Development stage: Other

Overview

Zero Pharm is a South Korean pharmaceutical company specializing in advanced drug delivery systems (DDS), particularly orally disintegrating tablets (ODT) and films (ODF). The company's proprietary Z-ODT platform enables the development of medications that dissolve rapidly in the mouth without water, improving patient compliance for populations with swallowing difficulties, such as the elderly or those with CNS disorders. Zero Pharm's pipeline includes treatments for Alzheimer's disease, Parkinson's disease, and erectile dysfunction. By focusing on value-added generics and improved new drugs, the company aims to enhance the therapeutic efficacy and convenience of established molecules.

Therapeutic areas: NeurologyMen's Health
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Zero Pharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zero Pharm.

Explore the full profile